menu
    • menu

    Company profile for Aurion Biotech

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness. Our first candidate is for the treatment of corneal endothelial disease, and one of the first clinically validated cell therapies for corneal care

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aurion BiotechUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    701 Pike Street, Suite 2225, Seattle, WA 98101, United States
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://aurionbiotech.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/aurion-biotech/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/aurionbiotech

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aurion Bio Hits All Endpoints In AURN001 Ph 1/2 CLARA Trial
    Aurion Bio Hits All Endpoints In AURN001 Ph 1/2 CLARA Trial

    18 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251018009011/en/Aurion-Biotech-Achieves-All-Primary-Secondary-and-Exploratory-Endpoints-in-AURN001-Phase-12-CLARA-Trial-at-12-Months

    BUSINESSWIRE
    18 Oct 2025
    Share Share
    Aurion Bio Promotes Torres To Chief Manufacturing Officer
    Aurion Bio Promotes Torres To Chief Manufacturing Officer

    30 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250930926770/en/Aurion-Biotech-Expands-Leadership-Team-Promoting-Andrew-Torres-Ph.D.-to-Chief-Manufacturing-Officer-and-Sterling-Chung-to-Chief-Regulatory-Quality-Officer

    BUSINESSWIRE
    30 Sep 2025
    Share Share
    Aurion Biotech names Edward J. Holland Chief Medical Officer
    Aurion Biotech names Edward J. Holland Chief Medical Officer

    23 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250423074583/en/Aurion-Biotech-Appoints-Edward-J.-Holland-M.D.-as-Chief-Medical-Officer-and-Eris-P.-Jordan-O.D.-as-Chief-Development-Officer

    BUSINESSWIRE
    23 Apr 2025
    Share Share
    Alcon Acquires Majority in Aurion Biotech to Advance Cell Therapy
    Alcon Acquires Majority in Aurion Biotech to Advance Cell Therapy

    27 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250326223440/en/Alcon-Acquires-Majority-Interest-in-Aurion-Biotech-Inc.-to-Advance-Innovative-Cell-Therapy-for-Corneal-Endothelial-Disease

    BUSINESSWIRE
    27 Mar 2025
    Share Share
    Aurion Biotech Named To Most Innovative Companies 2025
    Aurion Biotech Named To Most Innovative Companies 2025

    18 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250318365393/en/Aurion-Biotech-Named-to-Fast-Companys-Annual-List-of-the-Worlds-Most-Innovative-Companies-of-2025

    BUSINESSWIRE
    18 Mar 2025
    Share Share
    Aurion Biotech Appoints Donald Munoz as Chief Financial Officer
    Aurion Biotech Appoints Donald Munoz as Chief Financial Officer

    10 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250210293269/en

    BUSINESSWIRE
    10 Feb 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search